Clinical Trial Update: A Trial of Telmisartan Prevention of Cardiovascular Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating telmisartan for the prevention of cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Kumamoto University | Conditions: Hypertension | Phase 4 | Status: COMPLETED